相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PET/CT radiomics in breast cancer: Mind the step
Martina Sollini et al.
METHODS (2021)
Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement
Ji Eun Park et al.
EUROPEAN RADIOLOGY (2020)
Affibody Molecules as Targeting Vectors for PET Imaging
Vladimir Tolmachev et al.
CANCERS (2020)
Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging
Hai-Jeon Yoon et al.
BREAST JOURNAL (2019)
18F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases
Lea Cuppari et al.
CLINICAL NUCLEAR MEDICINE (2019)
Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
Xuejin Ou et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2019)
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
Lidija Antunovic et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer
Emine Acar et al.
NUCLEAR MEDICINE COMMUNICATIONS (2019)
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters
Hyunjong Lee et al.
CLINICAL NUCLEAR MEDICINE (2019)
PET/MRI in Breast Cancer
Akshat C. Pujara et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)
Comparative Study between 18F FDG-PET/CT and Whole Body MRI DWIBS in Assessment of Recurrent Breast Cancer (Prospective, Comparative, Cross-sectional Study Design)
Mahmoud Rezk et al.
INDIAN JOURNAL OF NUCLEAR MEDICINE (2019)
Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features
Wolf-Dieter Vogl et al.
EUROPEAN RADIOLOGY EXPERIMENTAL (2019)
Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer
K. Kutluturk et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2019)
Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer
Alexis Moscoso et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
Thiemo J. A. van Nijnatten et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy
Nariya Cho et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using Zr-89-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Tumor Uptake of Cu-64-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
Joanne E. Mortimer et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate
David Molina-Garcia et al.
ANNALS OF NUCLEAR MEDICINE (2018)
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure
M. E. M. van der Noordaa et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer
Kanae K. Miyake et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Early re-staging and molecular subtype shift surveillance of locally recurrent or metastatic breast cancer: A new PET/CT integrated precise algorithm
Wei Guo et al.
CANCER LETTERS (2018)
Synchronous Detection of Male Breast Cancer and Prostatic Cancer in a Patient With Suspected Prostatic Carcinoma on 68Ga-PSMA PET/CT Imaging
Rajender Kumar et al.
CLINICAL NUCLEAR MEDICINE (2018)
68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer
Averilicia Passah et al.
CLINICAL NUCLEAR MEDICINE (2018)
Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan
Harkanwar S. Gill et al.
CLINICAL NUCLEAR MEDICINE (2018)
68Ga-Labeled PSMA Uptake in Nonprostatic Malignancies: Has the Time Come to Remove PS From PSMA?
Dharmender Malik et al.
CLINICAL NUCLEAR MEDICINE (2018)
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer
David Groheux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
Jingjing Zhang et al.
THERANOSTICS (2018)
68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study
Jie Zang et al.
CLINICAL NUCLEAR MEDICINE (2018)
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma
Ashwin Singh Parihar et al.
CLINICAL NUCLEAR MEDICINE (2018)
Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
Shih-ying Huang et al.
NPJ BREAST CANCER (2018)
Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast
Averilicia Passah et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy
Frank I. Lin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Almir G. V. Bitencourt et al.
EUROPEAN RADIOLOGY (2017)
MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer
Maria J. Garcia-Velloso et al.
EUROPEAN RADIOLOGY (2017)
A Randomized Feasibility Study of 18F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor Rich Postmenopausal Breast Cancer
Sun Young Chae et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
[18F] FDG PET/CT features for the molecular characterization of primary breast tumors
Lidija Antunovic et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT
Dan Sandberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer
Yong-il Kim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients
Charles Lemarignier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer
Gary A. Ulaner et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
PET/MRI of the breast
Donna M. Plecha et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET/MRI system in breast cancer: A feasibility study
Amarnath Jena et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review
Fangfang Tian et al.
EUROPEAN RADIOLOGY (2017)
Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast
Onofrio Antonio Catalano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Complete Metabolic Response on Interim 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Suyun Chen et al.
ONCOLOGIST (2017)
Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
Seunggyun Ha et al.
SCIENTIFIC REPORTS (2017)
Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy
Nariya Cho et al.
JAMA ONCOLOGY (2017)
A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
Chengcheng Gong et al.
SCIENTIFIC REPORTS (2017)
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A. Ulaner et al.
CLINICAL NUCLEAR MEDICINE (2017)
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun et al.
CLINICAL CANCER RESEARCH (2017)
64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer
S. Sasada et al.
ANNALS OF ONCOLOGY (2017)
Predictive Value of 18F-FDG PET/CT for Axillary Lymph Node Metastasis in Invasive Ductal Breast Cancer
Bong-Il Song et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Multiparametric Evaluation of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer Using Integrated PET/MR
Jane Wang et al.
CLINICAL NUCLEAR MEDICINE (2017)
Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer
Mohan J. Roop et al.
CLINICAL NUCLEAR MEDICINE (2017)
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype
Onofrio Antonio Catalano et al.
BRITISH JOURNAL OF CANCER (2017)
FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer
Gary A. Ulaner et al.
CLINICAL NUCLEAR MEDICINE (2017)
Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging
Diomidis Botsikas et al.
EUROPEAN RADIOLOGY (2016)
Outcome of Small Lung Nodules Missed on Hybrid PET/MRI in Patients With Primary Malignancy
Roy A. Raad et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI Preliminary Observation
Nathaniel E. Margolis et al.
CLINICAL NUCLEAR MEDICINE (2016)
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery A Comparison Study With Dynamic Contrast Enhanced MRI
Yong-il Kim et al.
CLINICAL NUCLEAR MEDICINE (2016)
Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
Lino M. Sawicki et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
[18F] Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy
Malene Grubbe Hildebrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study
Funmilayo I. Tade et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Comparison of Whole-Body 18F FDG PET/MR Imaging and Whole-Body 18F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer
Amy N. Melsaether et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis
Shifu Tang et al.
PLOS ONE (2016)
Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy
Nurhan Ergul et al.
ACTA RADIOLOGICA (2015)
Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI
Maxine S. Jochelson et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma
Tae Hee Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
O. A. Catalano et al.
BRITISH JOURNAL OF CANCER (2015)
Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T
Heinrich F. Magometschnigg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Vertebral, rib, and intraspinal anomalies in congenital scoliosis: a study on 202 Caucasians
Hassan Ghandhari et al.
EUROPEAN SPINE JOURNAL (2015)
Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging
Johannes Grueneisen et al.
INVESTIGATIVE RADIOLOGY (2015)
Effectiveness of Breast MRI and 18F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma
Na Young Jung et al.
JOURNAL OF BREAST CANCER (2015)
Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
Yeong Yi An et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study
Katja Pinker et al.
CLINICAL CANCER RESEARCH (2014)
89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
Sietske B. M. Gaykema et al.
CLINICAL CANCER RESEARCH (2014)
Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
Kenneth E. Pengel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Simultaneous whole-body 18F-FDG PET-MRI in primary staging of breast cancer: A pilot study
Sangeeta Taneja et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Multiparametric Evaluation of Breast Lesions Using PET-MRI Initial Results and Future Perspectives
Almir G. V. Bitencourt et al.
MEDICINE (2014)
111In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment
Sietske B. M. Gaykema et al.
MOLECULAR IMAGING (2014)
Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer
Mary L. Gemignani et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis
Yuting Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer
David Groheux et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results
T. A. Heusner et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
M. Pennant et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
PET in women with high risk for breast or ovarian cancer
Einat Even-Sapir et al.
LANCET ONCOLOGY (2010)
Correlation between Quantified Breast Densities from Digital Mammography and 18F-FDG PET Uptake
Paras Lakhani et al.
BREAST JOURNAL (2009)
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Amandeep Kumar et al.
EUROPEAN RADIOLOGY (2009)
Initial Characterization of a Dedicated Breast PET/CT Scanner During Human Imaging
Spencer L. Bowen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II
Lawrence MacDonald et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
Sara Ahlgren et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1-Overview, Detection, and Staging
Jean H. Lee et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk
Bingsheng Huang et al.
RADIOLOGY (2009)
Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors
Kazuhiro Kitajima et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters
Sandip Basu et al.
CANCER (2008)
Tumor metabolism and blood flow changes by positron emission tomography: Relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer
Lisa K. Dunnwald et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol
Lanell M. Peterson et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Patterns of αvβ3 expression in primary and metastatic human breast cancer as shown by 18F-galacto-RGD PET
Ambros J. Beer et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Breast cancer staging in a single session: Whole-body PET/CT mammography
Till A. Heusner et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Bone metastases in patients with metastatic breast cancer: Morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT
Ukihide Tateishi et al.
RADIOLOGY (2008)
Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
Laura Kenny et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Fusion of metabolic function and morphology:: Sequential [18F] fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer
Yong Du et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: A prospective study with intraoperative confirmation
E. D. Rappeport et al.
ACTA RADIOLOGICA (2007)
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sequential positron emission tomography using [18F] fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer
Olivier Couturier et al.
CLINICAL CANCER RESEARCH (2006)
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Powerful prognostic stratification by [18F] fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy
Florent Cachin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma
ER Port et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Diagnostic performance of digital versus film mammography for breast-cancer screening
ED Pisano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Evolving role of positron emission tomography in breast cancer imaging
WB Eubank et al.
SEMINARS IN NUCLEAR MEDICINE (2005)
FDG-PET and beyond: Molecular breast cancer imaging
A Quon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: Initial experience
EL Rosen et al.
RADIOLOGY (2005)
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging breast cancer with PET study group
RL Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography
FJ van Oost et al.
EUROPEAN JOURNAL OF CANCER (2004)
Biological characterisation of breast cancer by means of PET
AK Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
PET with [18F]fluorothymidine for imaging of primary breast cancer:: a pilot study
B Smyczek-Gargya et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Positron emission mammography: Initial clinical results
EA Levine et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer
WB Eubank et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations
N Avril et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
M Schelling et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
